Orbimed Advisors LLC’s Oric Pharmaceuticals Inc Position
Does Orbimed Advisors LLC own Oric Pharmaceuticals Inc (ORIC)? Yes — 2.69M shares worth $34M (+0.68% of its 13F portfolio) as of Q1 2026, down from 3.64M shares the prior filed quarter.
Position Value
$34M
Q1 2026
Shares
2.69M
% of Portfolio
+0.68%
Quarters Held
22
currently held
Position History ORIC
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 2.69M | $34M | +0.68% |
| Q4 2025 | 3.64M | $30M | +0.61% |
| Q3 2025 | 3.64M | $44M | +1.03% |
| Q2 2025 | 899.3K | $9M | +0.23% |
| Q1 2025 | 700.0K | $4M | +0.09% |
| Q2 2024 | 287.1K | $2M | +0.04% |
| Q1 2024 | 287.1K | $4M | +0.07% |
| Q4 2023 | 523.0K | $5M | +0.10% |
| Q3 2023 | 893.7K | $5M | +0.11% |
| Q2 2023 | 1.17M | $9M | +0.16% |
| Q1 2023 | 1.37M | $8M | +0.15% |
| Q4 2022 | 1.61M | $9M | +0.18% |
| Q3 2022 | 2.09M | $7M | +0.12% |
| Q2 2022 | 2.09M | $9M | +0.17% |
| Q1 2022 | 2.09M | $11M | +0.18% |
| Q4 2021 | 2.34M | $34M | +0.44% |
| Q3 2021 | 2.34M | $49M | +0.54% |
| Q2 2021 | 2.34M | $41M | +0.42% |
| Q1 2021 | 2.34M | $57M | +0.54% |
| Q4 2020 | 2.92M | $99M | +0.87% |
| Q3 2020 | 2.92M | $73M | +0.92% |
| Q2 2020 | 2.92M | $99M | +1.39% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of ORIC.